Monday - November 16, 2026
Institute of Genetics & Cancer: Obesity Drug Heart Benefits Not Just Due to Weight Loss
September 25, 2026
EDINBURGH, Scotland, Sept. 25 (TNSjou) -- The University of Edinburgh College of Medicine and Veterinary Medicine - Institute of Genetics and Cancer issued the following news:

* * *

Obesity drug heart benefits not just due to weight loss

The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.

Researchers examined known ri . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products